IPO registrations (S-1, F-1) · Registrants
U.S. Stem Cell, Inc.
- SEC CIK
- 1388319 · filings on EDGAR ↗
- Former names
- BIOHEART, INC. (2007–2015)
- Registration
- Form S-1, first filed 2007-02-13, last 2016-02-02; 4 initial registrations, 10 amendments
- Outcome
- Final prospectus filed 2008-02-21; declared effective 2007-10-02
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- FL
- Business address
- 1560 SAWGRASS CORPORATE PKWY, 4TH FLOOR, Sunrise, FL 33323
- EIN
- 65-0945967
- EDGAR entity type
- operating
- Insiders and CEO pay
- U.S. Stem Cell, Inc. on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2007-10-01)
- Final price
- $5.25 per share, below the range (424B4 filed 2008-02-21, an initial public offering)
- Shares sold
- 1,100,000
- Gross proceeds
- $5,775,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol BHRT
- Lead underwriters
- Dawson James (1,000,000 shares)
- Syndicate
- Newbridge Securities Corporation (100,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: U.S. STEM CELL, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: US STEM CELL INC EXACT (EIN (EXACT))
- Form D issuer: U.S. Stem Cell, Inc. EXACT (CIK (EXACT))
- SEC filer: BIOHEART, INC. EXACT (CIK (EXACT))
- Person page: Alan P Timmins Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Sheldon T Anderson Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 21
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2007-02-13 | S-1 | S-1 (registration) | BIOHEART, INC. | 0000950144-07-001174 ↗ |
| 2007-06-05 | S-1/A | S-1/A (amendment) | BIOHEART, INC. | 0000950144-07-005484 ↗ |
| 2007-07-12 | S-1/A | S-1/A (amendment) | BIOHEART, INC. | 0000950144-07-006518 ↗ |
| 2007-08-09 | S-1/A | S-1/A (amendment) | BIOHEART, INC. | 0000950144-07-007544 ↗ |
| 2007-09-06 | S-1/A | S-1/A (amendment) | BIOHEART, INC. | 0000950144-07-008419 ↗ |
| 2007-10-01 | S-1/A | S-1/A (amendment) | BIOHEART, INC. | 0000950144-07-008951 ↗ |
| 2007-10-02 | EFFECT | EFFECT (declared effective) | BIOHEART, INC. | 9999999995-07-003905 ↗ |
| 2008-02-14 | EFFECT | EFFECT (declared effective) | BIOHEART, INC. | 9999999995-08-000558 ↗ |
| 2008-02-21 | 424B4 | 424B4 (final prospectus) | BIOHEART, INC. | 0000950144-08-001260 ↗ |
| 2012-01-19 | S-1 | S-1 (registration) | BIOHEART, INC. | 0001145443-12-000051 ↗ |
| 2012-02-08 | S-1/A | S-1/A (amendment) | BIOHEART, INC. | 0001145443-12-000087 ↗ |
| 2012-02-09 | S-1/A | S-1/A (amendment) | BIOHEART, INC. | 0001145443-12-000094 ↗ |
| 2012-02-09 | S-1/A | S-1/A (amendment) | BIOHEART, INC. | 0001145443-12-000096 ↗ |
| 2012-02-10 | EFFECT | EFFECT (declared effective) | BIOHEART, INC. | 9999999995-12-000461 ↗ |
| 2013-05-07 | EFFECT | EFFECT (declared effective) | BIOHEART, INC. | 9999999995-13-001417 ↗ |
| 2014-11-21 | S-1 | S-1 (registration) | BIOHEART, INC. | 0001145443-14-001389 ↗ |
| 2014-12-12 | S-1/A | S-1/A (amendment) | BIOHEART, INC. | 0001145443-14-001467 ↗ |
| 2014-12-22 | EFFECT | EFFECT (declared effective) | BIOHEART, INC. | 9999999995-14-003776 ↗ |
| 2015-12-14 | S-1 | S-1 (registration) | U.S. Stem Cell, Inc. | 0001185185-15-003299 ↗ |
| 2016-02-02 | S-1/A | S-1/A (amendment) | U.S. Stem Cell, Inc. | 0001185185-16-003572 ↗ |
| 2016-02-12 | EFFECT | EFFECT (declared effective) | U.S. Stem Cell, Inc. | 9999999995-16-003756 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2007-10-01 | S-1/A | registration statement | $14.00–$16.00 | 3,575,000 | - | Nasdaq BHRT | 4 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2008-02-21 | 424B4 | final prospectus | $5.25 | 1,100,000 | $5,775,000 | Nasdaq BHRT | 2 | primary document; price sentence, shares headline, proceeds table, underwriting table 2, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| AHN SAMUEL S | Director; Director,TenPercentOwner | 18 | 2007–2015 | ||
| BURKE NICHOLAS M | Officer | VP of Financial Operations | 1 | 2007 | |
| CARSON BRUCE C | Director | 5 | 2007–2011 | ||
| FARLEY PEGGY A | Director; Director,Officer | CFO & COO; COO & CFO | 9 | 2007–2010 | |
| GURY DAVID J | Director | 2 | 2007–2008 | ||
| KLINE WILLIAM H | Officer | Chief Financial Officer | 1 | 2007 | |
| Leonhardt Brenda Lee | TenPercentOwnerOther | 3 | 2007–2008 | ||
| Leonhardt Howard J | Director,Officer,TenPercentOwner | Chairman, CEO & CTO; Chief Technology Officer; Executive Chairman & CTO | 7 | 2007–2011 | |
| MURPHY WILLIAM P JR | Director; Director,TenPercentOwner | 39 | 2007–2021 | ||
| Pinon William M | Director,Officer | President & CEO | 1 | 2007 | |
| SCOTT BROMLEY R | Officer | VP of Public Relations | 2 | 2007–2009 | |
| SPENCER RICHARD III | Director | 5 | 2007–2011 | ||
| SPENCER RICHARD T IV | Officer | VP Clinical Affairs & Phys Rel | 1 | 2007 | |
| SULAWSKE-GUCK CATHERINE | Officer | Chief Operating Officer; Vice President, Admin. & HR; VP Admin & HR, Corp Secretary; VP of Admin & HR; VP of Administration and HR | 6 | 2007–2011 | |
| TOMAS MIKE | Director; Director,Officer | CEO & President; President & CEO | 38 | 2007–2019 | |
| TUFTS LINDA | Director | 2 | 2007–2008 | ||
| TIMMINS ALAN P | Director | 1 | 2008 | person page Fuzzy | |
| Borman Mark P | Director | 14 | 2009–2019 | ||
| Groth Karl | Director; Director,Officer | Chief Executive Officer | 2 | 2009–2010 | |
| Hart Charles A | Director | 18 | 2009–2015 | ||
| Comella Kristin C | Director,Officer; Officer | Chief Science Officer; Chief Scientific Officer; Vice President,R&D & Corp Dev; Vice President,R&D & Corp.Dev | 15 | 2009–2018 | |
| Fendrich Matthew J | Officer | Vice President,Sales&Marketing | 2 | 2009 | |
| Lee A Jones | Director | 2 | 2009–2010 | ||
| Anderson Sheldon T. | Director | 8 | 2014–2019 | person page Fuzzy | |
| Knutson Gregory | Director | 7 | 2017–2022 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2021-02-22 | U.S. Stem Cell, Inc. | Other Health Care | Indefinite | $190,000 | 3 | 1 |
| 2018-05-04 | U.S. Stem Cell, Inc. | Other Health Care | Indefinite | $323,000 | 8 | 1 |
| 2014-10-31 | BIOHEART, INC. | Biotechnology | $3,150,000 | $150,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | U.S. STEM CELL, INC. | FL | State business registries | name and state |
| Plan sponsor | US STEM CELL INC | FL | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | U.S. Stem Cell, Inc. | FL | Form D private offerings | CIK (EXACT) |
| SEC filer | U.S. Stem Cell, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | U.S. Stem Cell, Inc. | FL | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | US STEM CELL INC | EIN (EXACT) | ||
| Person page | Alan P Timmins | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Sheldon T Anderson | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, FL first:
- LIFESYNC HOLDINGS INC FL
- FOXO TECHNOLOGIES INC. FL
- Hesperos, Inc FL
- IB Acquisition Corp. FL
- COMBICHEM INC CA
- AURORA BIOSCIENCES CORP CA
- DGI RESOLUTION INC K6
- PRA INTERNATIONAL INC VA
- QUEST DIAGNOSTICS INVESTMENTS INC NJ
- SIGNAL PHARMACEUTICALS INC CA
In other datasets, the same topic (Medical research) in FL:
- Nonprofit: AASCM INC (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research